Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation

Inflammation Research

Volumn 54, Issue 1, 2005, Pages 37-41

  Liu, L ^a   Wang, Y X ^a   Zhou, J ^a   Long, F ^a   Sun, H W ^a   Liu, Y ^a   Chen, Y Z ^a   Jiang, C L ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti inflammation; Degranulation; Glucocorticoids; Neutrophil; Non genomic action

Indexed keywords

CYCLOHEXIMIDE; CYTOCHALASIN B; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLUCOCORTICOID; HYDROCORTISONE; LACTOFERRIN; METHYLPREDNISOLONE; MIFEPRISTONE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEGRANULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; GENOMICS; HUMAN; HUMAN CELL; NEUTROPHIL;

CELL DEGRANULATION; GENE EXPRESSION REGULATION; GENOMICS; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; METHYLPREDNISOLONE; MIFEPRISTONE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 15244343080     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1320-y     Document Type: Article

References (36)

1. Goppelt-Struebe M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem Pharmacol 1997; 53: 1389-95.
2. Reichardt HM, Tronche F, Berger S, Kellendonk C, Schutz G. New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. Adv. Pharmacol 2000; 47: 1-21.
3. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-41.
4. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71.
5. Duval D, Durant S, Homo-Delache F. Non-genomic effects of steroids. Interactions of steroid molecules with membrane structures and functions. Biochim Biophys Acta 1983; 737: 409-42.
6. Losel R, Wehling M. Non-genomic actions of steroid hormones. Nat Rev Mol Cell Biol 2003; 4: 46-56.
7. Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids 2002; 67: 529-34.
8. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K et al. Non-genomic steroid action: controversies, questions, and answers. Physiol Rev 2003; 83: 965-1016.
9. 4 by purified human neutrophils. J Pharmacol Exp Ther 1989; 250: 598-605.
10. + into concanavalin A-stimulated thymocytes. Biochem J 1997; 326: 329-32.
11. Pentikainen PJ. Pharmacological aspects of corticosteroid pulse therapy. Scand J Rheumatol 1984; 541: 6-9.
12. Goulding NJ, Euzger HS, Butt SK, Perretti M. Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflamm Res 1998; 47: S158-65.
13. Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ et al. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum 1997; 40: 1400-08.
14. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS et al. A randomized, controlled trial of methylprednisolone or naloxane in the treatment of acute spinal cord injury. N Engl J Med 1990; 322: 1405-11.
15. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1635-9.
16. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986-94.
17. Oba Y. The use of corticosteroids in SARS. N Engl J Med 2003; 348: 2034-5.
18. Weissmann G, Dingle JT. Release of lysosomal protease by ultraviolet irradiation and inhibition by hydrocortisone. Exp Cell Res 1961; 25: 207-10.
19. Thompson EB. Glucocorticoids and lysosomes. In: Baxter JD and Rousseau GG. (eds.) Glucocorticoid hormone action, Springer-Verlag, Berlin, Heidelberg, New York, 1979; pp. 575-81.
20. Alamo C, Ferrandiz B, Lopez-Munoz F, Alguacil LF. Influence of butibufen on enzyme activity and lysosomal stabilization ex vivo: a comparative study with hydrocortisone and acetylsalicylic acid. Meth. Find. Exp Clin Pharmacol 1995; 17: 303-10.
21. Ignarro LJ. Lysosome membrane stabilization in vivo: effects of steroidal and non-steroidal anti-inflammatory drugs on the integrity of rat liver lysosomes. J Pharmacol Exp Ther 1972; 182: 179-88.
22. Hinz B, Hirschelmann R. Dexamethasone megadoses stabilize rat liver lysosomal membranes by non-genomic and genomic effects. Pharma Res 2000; 17: 1489-93.
23. Ignarro LJ. Dissimilar effects of anti-inflammatory drugs on stability of lysosomes from peritoneal and circulating leukocytes and liver. Biochem Pharmacol 1971; 20: 2861-70.
24. Smith RJ. Phagocytic release of lysosomal enzymes from guinea pig neutrophils-regulation by corticosteroids, autonomie neurohormones and cyclic nucleotides. Biochem Pharmacol 1977; 26: 2001-9.
25. Persellin RH, Ku LC. Effects of steroid hormones on human polymorphonuclear leukocyte lysosomes. J Clin Invest 1974; 54: 919-25.
26. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985; 119: 101-10.
27. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503-21.
28. Webster RO, Henson PM. Rapid micromeasurement of neutrophil exocytosis. Inflammation 1978; 3: 129-35.
29. Mocsai A, Ligeti E, Lowell CA, Berton G. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. J Immunol 1999; 162: 1120-6.
30. Sengelov H, Kjeldsen L, Borregaard N. Control of exocytosis in early neutrophil activation. J Immunol 1993; 150: 1535-43.
31. Dallegri F, Ottonello L. Tissue injury in neutrophilic inflammation. Inflamm Res 1997; 46: 382-91.
32. Boxer LA, Smolen JE. Neutrophil granule constituents and their release in health and disease. Hematol Oncol Clin North Am 1988; 2: 101-34.
33. Dupont GD, Deby C, Lamy M. Neutrophil myeloperoxidase revisited: it's role in health and disease. Intensiv med 1999; 36: 500-13.
34. Schleimer RP, Bochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994; 94: 1202-13.
35. Taieb J, Delarche C, Ethuin F, Selloum S, Poynard T, Gougerot-Pocidalo MA et al. Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophils. J Leukoc Biol 2002; 72: 1142-7.
36. Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D et al. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J 2004; 18: 70-80.